Adoption of adjuvant bisphosphonates for early breast cancer into standard clinical practice: Challenges and lessons learnt from comparison of the UK and Australian experience

International guidelines recommend adjuvant bisphosphonates (BPs) for post-menopausal women with early breast cancer to reduce recurrence and mortality. However, globally, wide variation exists in their adoption. In the UK, adjuvant BPs were a recommendation in the breast cancer Clinical Reference G...

Descripción completa

Detalles Bibliográficos
Autores principales: Porter, I., Theodoulou, E., Holen, I., Harper-Wynne, C., Baron-Hay, S., Wilson, C., Brown, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581365/
https://www.ncbi.nlm.nih.gov/pubmed/34804788
http://dx.doi.org/10.1016/j.jbo.2021.100402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581365/
https://www.ncbi.nlm.nih.gov/pubmed/34804788
http://dx.doi.org/10.1016/j.jbo.2021.100402

Ejemplares similares